City in eastern DRC, capital of North Kivu, near Lake Kivu and Mount Nyiragongo
The Bundibugyo-strain Ebola outbreak in the DR Congo has intensified, with cases rising and deaths increasing. Health workers are striking over unpaid salaries, while international partners warn the official figures may undercount the true toll. Trials for treatments have begun, and vaccination efforts remain limited by the absence of a vaccine for this strain.
Frontline workers at Ituri’s Ebola response facilities have struck over unpaid wages as the Bundibugyo outbreak expands to more provinces. The situation adds strain to an already overwhelmed health system, with clinics at capacity and mistrust hampering containment efforts. New cases have been confirmed in Haut-Uele and Tshopo, raising the outbreak’s regional footprint.
Uganda has declared the end of its 2026 Ebola outbreak after completing a 42‑day monitoring period. Twenty confirmed cases were recorded, 18 recovered and two deaths, with most cases linked to Congo’s outbreak. Authorities say there is no evidence of further transmission and the Bundibugyo strain remains without a vaccine or treatment.
The latest updates show the Bundibugyo-virus outbreak has grown rapidly in Congo, with thousands of cases and over a thousand deaths reported. The virus has no approved vaccines or treatments, distinguishing this outbreak from the 2014-2016 crisis.
The M23 rebel group has accepted 15 prisoners released under a Qatar-mediated deal, a move that could pave the way for broader peace in eastern DRC. ICRC facilitated the transfer between Beni and Rutshuru, with Qatar welcoming the step as confidence-building toward sustainable solutions. Critics remain wary as Rwanda’s role draws scrutiny from the U.N. and Western powers.
The DRC has recorded the largest-ever Bundibugyo Ebola outbreak, with more than 5,600 confirmed cases and over 2,700 deaths, and international agencies are racing to respond. WHO and partners have allocated 70,000 Ervebo doses—20,000 for a Phase III trial and 50,000 for frontline workers—while CEPI has awarded up to $16.5m to advance a Minapharm Bundibugyo vaccine into early human trials. Uganda has received MBP134 antibody vials as a precautionary measure.
Since mid‑May the Democratic Republic of Congo has recorded more than 5,600 Ebola cases and about 2,700 deaths; the outbreak has spread across six provinces and is covering an area larger than France. The UN and aid groups have warned infections are rising faster than the international response, funding is running short and frontline workers face attacks and heavy losses.
The DR Congo government and M23 rebels have agreed on a roadmap for peace talks, backed by international mediators, to implement the Doha Framework. A ceasefire verification mission is set to monitor violations as fighting persists in North and South Kivu, with concerns over sanctions, detainees and political reforms.
Aliko Dangote has opened a month-long IPO for Dangote Petroleum Refinery, offering roughly 3% of the company to retail investors from 14 September with minimum purchases of 10 shares. The sale will fund plans to double capacity to about 1.4m barrels per day and expand listings outside Africa, while critics warn of concentration of ownership and valuation risks.
The Front for the Refoundation of the Nation has been unveiled in Goma, with Kabila declaring a coalition of resistance forces that could confront the Tshisekedi government. The move comes as M23 and AFC-aligned groups control parts of eastern DR Congo and as calls for constitutional changes grow. Analysts warn the development risks escalating violence and complicating peace efforts.